CDKN1A and ovarian carcinoma: In both ovarian cancer cell lines, SKOV3 and OVCAR3, BRD4 expression decreased, whereas CDKN1A (p21) gene expression and degradation of the cell cycle inhibitor CDKN1B/p27KIP1 (p27) increased in a dose-dependent manner.